Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $47.00 and last traded at $47.00, with a volume of 81027 shares traded. The stock had previously closed at $46.28.
Wall Street Analyst Weigh In
Separately, BNP Paribas lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
Check Out Our Latest Stock Analysis on SDZNY
Sandoz Group Stock Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- How to Use the MarketBeat Excel Dividend Calculator
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Are Penny Stocks a Good Fit for Your Portfolio?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to buy stock: A step-by-step guide for beginnersÂ
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
